Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Regulation of the stability of poly(I)xpoly(C)-induced human fibroblast interferon mRNA: selective inactivation of interferon mRNA and lack of involvement of 2',5'-oligo(A) synthetase activation during the shutoff of interferon production.
Sehgal PB, Gupta SL.
???displayArticle.abstract???
The inactivation of interferon mRNA during the shutoff phase of interferon production in poly(I)xpoly(C)-induced human fibroblast cultures is selective. We have determined that the shutoff of interferon production, which takes place from 3 to 8 hr after the beginning of induction, is not associated with an appreciable declined in the rate of bulk cellular protein synthesis or of cellular protein secretion. While the amount of translatable interferon mRNA declined markedly during the shutoff phase, the level of translatable bulk cellular mRNA and the stability of [3H]uridine-labeled mRNA were unaffected. Superinduction with actinomycin D selectively stabilized interferon mRNA with no apparent effect on the stability of bulk cellular mRNA. Furthermore, an activation of the 2',5'-oligo(A) synthetase/endonuclease system does not appear to be involved in the shutoff phenomenon. Uninduced FS-4 cells contained a low basal level of 2'5'-oligo(A) synthetase activity, which was unchanged in poly(I)xpoly(C)-induced cells during the shutoff phase. Treatment of FS-4 cells with interferon for 16-18 hr prior to induction increased the enzyme activity by approximately 200-fold. However, this did not inhibit interferon production after induction with poly(I)xpoly(C) alone or after superinduction with cycloheximide or actinomycin D or both. Furthermore, the rates of decay of interferon production were comparable in cells with either a basal or an increased level of 2',5'-oligo(A) synthetase. Thus a 200-fold increase in 2',5'-oligo(A) synthetase level did not affect either the stability of interferon mRNA or the efficacy of interferon superinduction by metabolic inhibitors.
Armstrong,
Semi-micro, dye-binding assay for rabbit interferon.
1971, Pubmed
Armstrong,
Semi-micro, dye-binding assay for rabbit interferon.
1971,
Pubmed Baglioni,
Interferon action may be mediated by activation of a nuclease by pppA2'p5'A2'p5'A.
1978,
Pubmed Cavalieri,
Induction and decay of human fibroblast interferon mRNA.
1977,
Pubmed
,
Xenbase Cereghini,
Studies on the efficiency of translation and on the stability of actin messenger ribonucleic acid in mouse sarcoma ascites cells.
1979,
Pubmed Chatterjee,
Superinduction of alpha 2u globulin by actinomycin D: evidence for drug-mediated increase in alpha 2u mRNA.
1979,
Pubmed Clemens,
Inhibition of cell-free protein synthesis by pppA2'p5'A2'p5'A: a novel oligonucleotide synthesized by interferon-treated L cell extracts.
1978,
Pubmed Enger,
Thionein gene expression in Cd++-variants of the CHO cell: correlation of thionein synthesis rates with translatable mRNA levels during induction, deinduction, and superinduction.
1979,
Pubmed GARREN,
A PARADOXICAL EFFECT OF ACTINOMYCIN D: THE MECHANISM OF REGULATION OF ENZYME SYNTHESIS BY HYDROCORTISONE.
1964,
Pubmed Guyette,
Prolactin-mediated transcriptional and post-transcriptional control of casein gene expression.
1979,
Pubmed Havell,
Production of high-titered interferon in cultures of human diploid cells.
1972,
Pubmed Hovanessian,
Increased nuclease activity in cells treated with pppA2'p5'A2'p5' A.
1979,
Pubmed Kerr,
Nature of inhibitor of cell-free protein synthesis formed in response to interferon and double-stranded RNA.
1977,
Pubmed Kerr,
pppA2'p5'A2'p5'A: an inhibitor of protein synthesis synthesized with an enzyme fraction from interferon-treated cells.
1978,
Pubmed Lowenhaupt,
Synthesis and turnover of globin mRNA in murine erythroleukemia cells induced with hemin.
1979,
Pubmed MCAUSLAN,
THE INDUCTION AND REPRESSION OF THYMIDINE KINASE IN THE POXVIRUS-INFECTED HELA CELL.
1963,
Pubmed Nilsen,
Mechanism for discrimination between viral and host mRNA in interferon-treated cells.
1979,
Pubmed Ratner,
Interferon, double-stranded RNA and RNA degradation. Fractionation of the endonucleaseINT system into two macromolecular components; role of a small molecule in nuclease activation.
1978,
Pubmed Sehgal,
Enhancement of human interferon production by neutral red and chloroquine: analysis of inhibition of protein degradation and macromolecular synthesis.
1975,
Pubmed Sehgal,
Superinduction of human fibroblast interferon production: further evidence for increased stability of interferon mRNA.
1978,
Pubmed Sehgal,
Halogenated benzimidazole ribosides, Novel inhibitors of RNA synthesis.
1978,
Pubmed Sehgal,
Human interferon production: superinduction by 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole.
1975,
Pubmed Sehgal,
Two mechanisms contribute to the superinduction of poly(I).poly(C)-induced human fibroblast interferon production.
1979,
Pubmed Sehgal,
An evaluation of messenger RNA competition in the shutoff of human interferon production.
1976,
Pubmed Sehgal,
Regulation of human interferon production. I. Superinduction by 5, 6-dichloro-1-beta-D-ribofuranosylbenzimidazole.
1976,
Pubmed Sehgal,
Interferon messenger RNA content of human fibroblasts during induction, shutoff, and superinduction of interferon production.
1977,
Pubmed
,
Xenbase Stark,
2-5A synthetase: assay, distribution and variation with growth or hormone status.
1979,
Pubmed Tan,
Regulation of cellular interferon production: enhancement by antimetabolites.
1970,
Pubmed Tan,
Human chromosome 21 dosage: effect on the expression of the interferon induced antiviral state.
1974,
Pubmed Tomkins,
Further evidence for posttranscriptional control of inducible tyrosine aminotransferase synthesis in cultured hepatoma cells.
1972,
Pubmed Vilcek,
Differential effects of actinomycin D and puromycin on the release of interferon induced by double stranded RNA.
1969,
Pubmed Vilcek,
Stabilization of interferon messenger RNA activity by treatment of cells with metabolic inhibitors and lowering of the incubation temperature.
1973,
Pubmed Williams,
Inhibition of protein synthesis by 2'-5' linked adenine oligonucleotides in intact cells.
1978,
Pubmed
